India's cheap weight-loss drugs could reshape global obesity fight
-
With India’s semaglutide patent expiring on 20 March, about 50 branded
generics are expected to enter the market.
1 hour ago
LONDON to HOLLAND & EU Countries.
YES EVERYTHING matters ABSOLUTELY, ... http://youtu.be/z7raOZyOMUM
ReplyDelete